Physician profile
Robert A Fishman
NPI 1982807921
$2,543.84
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $821 · 2020: $89.94 · 2021: $315 · 2022: $1,209 · 2024: $109.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $109.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $108.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $591.77 | 2019-2022 | |
| Abbvie INC. | $499.11 | 2022-2024 | |
| Sunovion Pharmaceuticals INC. | $286.98 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $127.38 | 2019-2022 | |
| Sk Life Science, INC. | $127.37 | 2021-2022 | |
| Lilly USA, LLC | $125.29 | 2020-2022 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $110.41 | 2022 | |
| Abbott Laboratories | $105.78 | 2021 | |
| Janssen Pharmaceuticals, INC | $103.79 | 2022 | |
| Alexion Pharmaceuticals, INC. | $76.67 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $59.10 | 2021 | |
| Mdd US Operations, LLC | $46.56 | 2022 | |
| Acorda Therapeutics, INC | $43.87 | 2022 | |
| Genentech USA, INC. | $43.39 | 2021-2022 | |
| Emd Serono, INC. | $40.19 | 2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $29.12 | 2019-2022 | |
| Bausch Health US, LLC | $27.42 | 2019 | |
| Neurocrine Biosciences, INC. | $21.26 | 2022 | |
| Acadia Pharmaceuticals INC | $17.90 | 2022 | |
| Arbor Pharmaceuticals, INC. | $17.80 | 2022 | |
| Celgene Corporation | $15.22 | 2022 | |
| Eisai INC. | $14.44 | 2022 | |
| Lundbeck LLC | $13.02 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Fishman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.